Cargando…

Prophylactic or therapeutic doses of heparins for COVID-19 infection? A retrospective study

BACKGROUND: Coronavirus disease 19 (COVID-19) is a global outbreak. COVID-19 patients seem to have relevant coagulative abnormalities, even if they are not typical of disseminated intravascular coagulopathy (DIC) of the kind seen in septicaemia. Therefore, anticoagulant therapy with heparins is incr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bolzetta, Francesco, Maselli, Monica, Formilan, Marino, Busonera, Flavio, Albanese, Paolo, Chiaromanni, Federica, Romano, Antonietta, Veronese, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667217/ https://www.ncbi.nlm.nih.gov/pubmed/33196991 http://dx.doi.org/10.1007/s40520-020-01750-6

Ejemplares similares

Subcutaneous hematomas from prophylactic heparin use
por: Koratala, Abhilash, et al.
Publicado: (2017)

High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
por: Kawada, Sanami, et al.
Publicado: (2013)

Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease
por: Sundaram, Gayathri, et al.
Publicado: (2022)

Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
por: Vergori, Alessandra, et al.
Publicado: (2021)

Therapeutic and Prophylactic Use of Oral, Low-Dose IFNs in Species of Veterinary Interest: Back to the Future
por: Frazzini, Sara, et al.
Publicado: (2021)

A Case of Hemorrhagic Myositis Associated With Prophylactic Heparin Use in Dermatomyositis
por: Bartl, Mery, et al.
Publicado: (2023)

Cost reduction associated with heparin-induced thrombocytopenia panel ordering for enoxaparin versus heparin for prophylactic and therapeutic use: A retrospective analysis in a community hospital setting
por: Menon, Harry, et al.
Publicado: (2018)

A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients
por: Giossi, Riccardo, et al.
Publicado: (2021)

A direct comparison of prophylactic low-molecular-weight heparin versus unfractionated heparin in neurosurgery: A meta-analysis
por: Macki, Mohamed, et al.
Publicado: (2019)

Dietary acrylamide and physical performance tests: A cross-sectional analysis
por: Veronese, Nicola, et al.
Publicado: (2021)

Prophylactic and therapeutic effect of AZT/3TC in RT-SHIV infected Chinese-origin rhesus macaques
por: Wang, Wei, et al.
Publicado: (2014)

Venous thrombotic events in severe and critically COVID-19 patients despite high dose prophylactic low-molecular-weight heparin
por: Visser, Chantal, et al.
Publicado: (2020)

Continuation of therapeutic dose heparin for critically ill patients with COVID-19
por: Bradbury, Charlotte A., et al.
Publicado: (2023)

Bleeding is associated with intravenous immunoglobulin and therapeutic plasma exchange use in heparin‐induced thrombocytopenia: A propensity matched analysis
por: Soares Ferreira Júnior, Alexandre, et al.
Publicado: (2021)

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial
por: Sholzberg, Michelle, et al.
Publicado: (2021)

Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update
por: Vitiello, Antonio, et al.
Publicado: (2021)

Dynapenic abdominal obesity and incident multimorbidity: findings from the English longitudinal study on ageing
por: Veronese, Nicola, et al.
Publicado: (2023)

Suicide risk in caregivers of people with dementia: a systematic review and meta-analysis
por: Solimando, Luisa, et al.
Publicado: (2022)

Utilisation of Prophylactic Mastectomy in 10 European Centres
por: Evans, D. G. R., et al.
Publicado: (1999)

Influence of discontinuation of prophylactic antimicrobial agent for trabeculectomy
por: Ushio, Yuuka, et al.
Publicado: (2023)

Bleeding and Thrombotic Risk in Low Dose Heparin Infusion as Compared to Standard Dose Heparin Infusion
por: Lutfi, Forat, et al.
Publicado: (2020)

Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients a systematic review and meta-analysis of randomized controlled trials
por: Bonfim, Luana C.M.G., et al.
Publicado: (2023)

The Potential Role of miRNAs in Cognitive Frailty
por: Carini, Giulia, et al.
Publicado: (2021)

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity
por: Cianci, G, et al.
Publicado: (2003)

Heparin Mimetics: Their Therapeutic Potential
por: Mohamed, Shifaza, et al.
Publicado: (2017)

Dynapenic abdominal obesity and susceptibility to fall: a prospective analysis of the Osteoarthritis Initiative
por: Veronese, Nicola, et al.
Publicado: (2023)

Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients
por: Stattin, K., et al.
Publicado: (2020)

Prophylactic anticoagulation with low molecular weight heparin in COVID-19: cohort studies in Denmark and Sweden
por: Lund, Lars Christian, et al.
Publicado: (2022)

Therapeutic versus prophylactic heparin for thromboprophylaxis in patients with COVID-19: weighing the costs and benefits. A rapid meta-analysis of randomized controlled trials
por: Dimosiari, Athina, et al.
Publicado: (2022)

Initial therapeutic anticoagulation with rivaroxaban compared to prophylactic therapy with heparins in moderate to severe COVID-19: results of the COVID-PREVENT randomized controlled trial
por: Rauch-Kröhnert, Ursula, et al.
Publicado: (2023)

Therapeutically dosed low molecular weight heparins in renal impairment: a nationwide survey
por: Jaspers, Tessa Corrine Catherina, et al.
Publicado: (2022)

Heparin enhances the furin cleavage of HIV‐1 gp160 peptides
por: Pasquato, A., et al.
Publicado: (2007)

Quality improvement project to enhance heparin safety in patients with haemodialysis in China
por: Tan, Qiu-zhen, et al.
Publicado: (2022)

Prophylactic and therapeutic vaccines for obesity
por: Na, Ha-Na, et al.
Publicado: (2014)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris
por: Amane, Hanmant S., et al.
Publicado: (2011)

Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin
por: Stutz, Lina, et al.
Publicado: (2022)

Pulmonary embolism caused by delayed heparin-induced thrombocytopenia in a patient who received prophylactic LMWH
por: Kumar, Mehandar, et al.
Publicado: (2012)

Early initiation of prophylactic heparin in severe traumatic brain injury is associated with accelerated improvement on brain imaging
por: Kim, Luke, et al.
Publicado: (2014)

The role of prophylactic use of low molecular weight heparin or aspirin in thromboembolic events in primary membranous nephropathy
por: Zou, Peimei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s4q4a7socsb19bohf8acfap8te